Product image of Meropeném Steriscience (Meropenem) supplied by GNH India

Meropeném Steriscience

Active Ingredient:
Meropenem
Origin:
EU

Meropeném Steriscience (Meropenem)

Meropenem, the active ingredient in Meropeném Steriscience, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats serious bacterial infections such as sepsis, meningitis, and hospital‑acquired pneumonia in adult and pediatric patients when prescribed by a qualified healthcare professional.

GNH India supplies Meropeném Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Steriscience B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropeném Steriscience, a carbapenem antibiotic, is employed for infections caused by susceptible Gram‑negative and Gram‑positive bacteria.

  • Complicated intra‑abdominal infections: effective treatment of infections within the abdominal cavity.
  • Complicated urinary tract infections: eradicates pathogens causing severe urinary infections.
  • Bacterial meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections.
  • Hospital‑acquired pneumonia: combats resistant organisms in ventilated patients.
  • Sepsis: provides broad‑spectrum coverage for systemic bacterial infections.

How It Works

  • Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins, disrupting peptidoglycan cross‑linking. This leads to loss of cell wall integrity and bacterial lysis, offering bactericidal activity against a wide range of aerobic and anaerobic organisms, including many resistant strains.

Side Effects

Adverse reactions may occur with meropenem therapy and should be monitored.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limiting.
  • Headache: transient discomfort.
  • Rash: erythematous skin eruption.
  • Infusion site phlebitis: pain or redness at the injection site.
  • Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disorders.
  • Clostridioides difficile colitis: severe diarrhea due to bacterial overgrowth.
  • Anaphylaxis: acute, potentially life‑threatening allergic reaction.
  • Renal toxicity: worsening kidney function.
  • Thrombocytopenia: reduced platelet count.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.

Precautions & Warnings

Prior to initiating therapy, consider the following safety measures.

  • Renal function: adjust dosage in patients with impaired kidney function.
  • Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams.
  • Seizure risk: monitor patients with a history of seizures or CNS disorders.
  • Pregnancy: use only when the potential benefit justifies the potential risk to the fetus.
  • Concurrent antibiotics: evaluate for possible antagonistic effects.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropeném Steriscience may interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid)

  • Valproic acid: reduces meropenem plasma concentrations, potentially compromising efficacy.
  • Phenobarbital: may lower meropenem levels, decreasing antibacterial activity.

Moderate Interactions (Monitor Closely)

  • Aminoglycosides: additive nephrotoxicity risk; monitor renal function.
  • Loop diuretics: may increase ototoxic potential when combined.
  • Warfarin: monitor INR as meropenem can alter anticoagulant effect.

Frequently Asked Questions

Meropeném Steriscience is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, hospital‑acquired pneumonia, and sepsis. It is used when the causative organisms are susceptible and when broad‑spectrum coverage is required.

Meropenem belongs to the carbapenem class and works by binding to penicillin‑binding proteins on bacterial cell walls. This inhibits the final steps of peptidoglycan synthesis, leading to weakened cell walls and bacterial lysis, providing a bactericidal effect against a wide range of Gram‑positive and Gram‑negative organisms.

The dosage of Meropeném Steriscience is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and renal function. The prescriber will select the appropriate dose, infusion rate, and duration of therapy according to clinical guidelines.

Safety data for meropenem in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual risk factors and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where needed), and necessary import documentation.

Meropeném Steriscience shares the broad‑spectrum activity typical of carbapenems, offering stability against many β‑lactamases. Compared with imipenem or ertapenem, meropenem provides a slightly broader Gram‑negative coverage and a lower risk of seizures, though individual patient factors and local resistance patterns guide the choice of agent.

Meropeném Steriscience should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Once prepared for infusion, use the solution promptly and discard any remaining product after the recommended in‑use period to maintain sterility.

The product is supplied as an injectable solution for intravenous administration. It is typically infused over a specified period, often 15‑30 minutes, depending on the dose and clinical protocol. Administration should be performed by qualified healthcare personnel in a controlled setting.

Serious adverse events include seizures, especially in patients with renal impairment or pre‑existing CNS disorders, Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, and renal toxicity. Prompt recognition and management of these events are essential.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics should avoid this product. Caution is also advised for individuals with a history of seizures, severe renal impairment, or those receiving interacting medications that could increase toxicity.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT